The global selmonitoring blood glucose system market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of diabetes and rising awareness about diabetes among people. The global selmonitoring blood glucose system market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into blood glucose meters, testing strips, lancets & lancing devices. On the basis of application it is segmented into type 2 diabetes (T2D), type 1 diabetes (T1D), gestational diabetes (GDM). On the basis of region it is segmented into North America (NA), Latin America (LA), Europe (EU), Asia Pacific & Middle East & Africa(APMEA). North America accounted for a major share in terms of revenue in 2016 owing to high prevalence rates for T2D and T1D in this region. In addition to this factor, there are also high levels of awareness about these diseases among people which has led to increased adoption rates for selmonitoring blood glucose systems in this region. However APMEA has emerged as one of the fastest growing regions owing to increasing number cases related with T2D and GDM across countries such as India and China which are witnessing rapid economic growth coupled with an increase in disposable income levels among people living there.
- The global population is aging and the number of people with diabetes is increasing.
- The prevalence of obesity has increased in many countries, which increases the risk for type 2 diabetes.
- There are more people living with type 1 diabetes than ever before, and they need to monitor their blood glucose levels regularly to avoid complications from the disease.
- More people are being diagnosed with prediabetes, a condition that can lead to type 2 diabetes if left untreated, so they may be motivated to monitor their blood glucose levels as well as those who have been diagnosed with type 2 diabetes already.
- New technologies such as continuous glucose monitors (CGM) have been developed that allow for more accurate monitoring of blood sugar levels.
Industry Growth Insights published a new data on “Self-Monitoring Blood Glucose System Market”. The research report is titled “Self-Monitoring Blood Glucose System Market research by Types (Blood Glucose meters, Testing strips, Lancets & Lancing Devices), By Applications (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes), By Players/Companies Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), Nova Biomedical (US)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Self-Monitoring Blood Glucose System Market Research Report
By Type
Blood Glucose meters, Testing strips, Lancets & Lancing Devices
By Application
Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes
By Companies
Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), Nova Biomedical (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Self-Monitoring Blood Glucose System Market Report Segments:
The global Self-Monitoring Blood Glucose System market is segmented on the basis of:
Types
Blood Glucose meters, Testing strips, Lancets & Lancing Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche (Switzerland)
- Abbott (US)
- LifeScan (US)
- Ascensia (Switzerland)
- Medtronic (Ireland), Dexcom (US)
- Ypsomed (Switzerland)
- B. Braun (Germany)
- Nipro (Japan), Sanofi (France)
- ARKRAY (Japan)
- Prodigy Diabetes Care (US)
- ACON Laboratories (US)
- Nova Biomedical (US)
Highlights of The Self-Monitoring Blood Glucose System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Glucose meters
- Testing strips
- Lancets & Lancing Devices
- By Application:
- Type 2 Diabetes
- Type 1 Diabetes
- Gestational Diabetes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Self-Monitoring Blood Glucose System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A self-monitoring blood glucose system (SMBG) is a wearable device that helps people with diabetes monitor their blood sugar levels. The device typically includes a sensor that attaches to the skin, and an app or website that users can use to track their blood sugar levels. SMBG devices can also include other features, such as alarms and reminders to check blood sugar levels.
Some of the major players in the self-monitoring blood glucose system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), Nova Biomedical (US).
The self-monitoring blood glucose system market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Self-Monitoring Blood Glucose System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Self-Monitoring Blood Glucose System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Self-Monitoring Blood Glucose System Market - Supply Chain
4.5. Global Self-Monitoring Blood Glucose System Market Forecast
4.5.1. Self-Monitoring Blood Glucose System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Self-Monitoring Blood Glucose System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Self-Monitoring Blood Glucose System Market Absolute $ Opportunity
5. Global Self-Monitoring Blood Glucose System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Type
5.3.1. Blood Glucose meters
5.3.2. Testing strips
5.3.3. Lancets & Lancing Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Self-Monitoring Blood Glucose System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Application
6.3.1. Type 2 Diabetes
6.3.2. Type 1 Diabetes
6.3.3. Gestational Diabetes
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Self-Monitoring Blood Glucose System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Self-Monitoring Blood Glucose System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Self-Monitoring Blood Glucose System Demand Share Forecast, 2019-2026
9. North America Self-Monitoring Blood Glucose System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Application
9.4.1. Type 2 Diabetes
9.4.2. Type 1 Diabetes
9.4.3. Gestational Diabetes
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Type
9.7.1. Blood Glucose meters
9.7.2. Testing strips
9.7.3. Lancets & Lancing Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Self-Monitoring Blood Glucose System Demand Share Forecast, 2019-2026
10. Latin America Self-Monitoring Blood Glucose System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Application
10.4.1. Type 2 Diabetes
10.4.2. Type 1 Diabetes
10.4.3. Gestational Diabetes
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Type
10.7.1. Blood Glucose meters
10.7.2. Testing strips
10.7.3. Lancets & Lancing Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Self-Monitoring Blood Glucose System Demand Share Forecast, 2019-2026
11. Europe Self-Monitoring Blood Glucose System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Application
11.4.1. Type 2 Diabetes
11.4.2. Type 1 Diabetes
11.4.3. Gestational Diabetes
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Type
11.7.1. Blood Glucose meters
11.7.2. Testing strips
11.7.3. Lancets & Lancing Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Self-Monitoring Blood Glucose System Demand Share, 2019-2026
12. Asia Pacific Self-Monitoring Blood Glucose System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Application
12.4.1. Type 2 Diabetes
12.4.2. Type 1 Diabetes
12.4.3. Gestational Diabetes
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Type
12.7.1. Blood Glucose meters
12.7.2. Testing strips
12.7.3. Lancets & Lancing Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Self-Monitoring Blood Glucose System Demand Share, 2019-2026
13. Middle East & Africa Self-Monitoring Blood Glucose System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Application
13.4.1. Type 2 Diabetes
13.4.2. Type 1 Diabetes
13.4.3. Gestational Diabetes
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Self-Monitoring Blood Glucose System Market Size and Volume Forecast by Type
13.7.1. Blood Glucose meters
13.7.2. Testing strips
13.7.3. Lancets & Lancing Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Self-Monitoring Blood Glucose System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Self-Monitoring Blood Glucose System Market: Market Share Analysis
14.2. Self-Monitoring Blood Glucose System Distributors and Customers
14.3. Self-Monitoring Blood Glucose System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche (Switzerland)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott (US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LifeScan (US)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Ascensia (Switzerland)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medtronic (Ireland), Dexcom (US)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ypsomed (Switzerland)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. B. Braun (Germany)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nipro (Japan), Sanofi (France)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. ARKRAY (Japan)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Prodigy Diabetes Care (US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. ACON Laboratories (US)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Nova Biomedical (US)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook